JNJ Stock Analysis
Johnson & Johnson
Diversified healthcare company with leading pharmaceutical and medical device businesses and decades of dividend growth.
HealthcareMega-capLow volatility
What This Gives You Exposure To
- →Pharmaceutical pipelines and patent cycles
- →Medical device innovation
- →US mega-cap healthcare exposure
- →Dividend income stream
Behavior Characteristics
- →Defensive, less correlated with economic cycles
- →Lower volatility relative to small-cap peers
- →Tends to hold up better in market sell-offs
- →Provides income cushion during drawdowns
Hidden Overlap
- ⚠VOO — Held in VOO (~1% weight)
- ⚠XLV — Major weight in Health Care Select Sector ETF (~8%)
Role in a Portfolio
Acts as
- →Defensive anchor
- →Volatility dampener
- →Income generator
Increases
- →Portfolio stability
- →Downside resilience
- →Dividend yield
Does not provide
- →High growth upside
- →Momentum exposure
Want the full 21-section investment memo?
Get quality scorecard, scenario analysis, valuation framework, and more.
Frequently asked questions
- What does JNJ stock analysis include?
- The JNJ analysis shows sector exposure, behavioral characteristics, ETF overlap detection, and portfolio role assessment. Sign in to access the full 21-section investment memo with quality scorecard and scenario analysis.
- Is Johnson & Johnson a good stock?
- PortfoMemo provides structural diagnostics — not investment advice. The analysis covers business quality, risk, and portfolio fit, but does not make buy or sell recommendations.
- What sector is JNJ in?
- Johnson & Johnson is classified in the Healthcare sector. Key themes include Pharmaceuticals, MedTech, Defensive.
- Is this financial advice?
- No. PortfoMemo is an informational diagnostic tool. It describes risks, exposure, and portfolio characteristics but never recommends specific trades or allocations.